vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.
TOOTSIE ROLL INDUSTRIES INC is the larger business by last-quarter revenue ($196.3M vs $151.7M, roughly 1.3× Nutex Health, Inc.). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs 7.8%, a 6.9% gap on every dollar of revenue. On growth, TOOTSIE ROLL INDUSTRIES INC posted the faster year-over-year revenue change (1.5% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $61.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 13.2%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
NUTX vs TR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $196.3M |
| Net Profit | $11.8M | $28.8M |
| Gross Margin | 30.4% | 35.7% |
| Operating Margin | 20.4% | 17.0% |
| Net Margin | 7.8% | 14.7% |
| Revenue YoY | -41.1% | 1.5% |
| Net Profit YoY | -80.8% | 27.9% |
| EPS (diluted) | $2.34 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $196.3M | ||
| Q3 25 | $267.8M | $232.7M | ||
| Q2 25 | $244.0M | $155.1M | ||
| Q1 25 | $211.8M | $148.5M | ||
| Q4 24 | $257.6M | $193.4M | ||
| Q3 24 | $78.8M | $225.9M | ||
| Q2 24 | $76.1M | $150.7M | ||
| Q1 24 | $67.5M | $153.2M |
| Q4 25 | $11.8M | $28.8M | ||
| Q3 25 | $55.4M | $35.7M | ||
| Q2 25 | $-17.7M | $17.5M | ||
| Q1 25 | $21.2M | $18.1M | ||
| Q4 24 | $61.6M | $22.5M | ||
| Q3 24 | $-8.8M | $32.8M | ||
| Q2 24 | $-364.0K | $15.6M | ||
| Q1 24 | $-364.0K | $15.8M |
| Q4 25 | 30.4% | 35.7% | ||
| Q3 25 | 57.8% | 34.1% | ||
| Q2 25 | 51.2% | 36.4% | ||
| Q1 25 | 55.9% | 35.3% | ||
| Q4 24 | 55.0% | 39.1% | ||
| Q3 24 | 27.8% | 34.1% | ||
| Q2 24 | 29.7% | 33.5% | ||
| Q1 24 | 15.1% | 32.7% |
| Q4 25 | 20.4% | 17.0% | ||
| Q3 25 | 48.7% | 13.9% | ||
| Q2 25 | 13.8% | 7.8% | ||
| Q1 25 | 38.1% | 15.5% | ||
| Q4 24 | 44.4% | 20.0% | ||
| Q3 24 | 12.3% | 15.6% | ||
| Q2 24 | 7.0% | 10.2% | ||
| Q1 24 | 2.1% | 7.3% |
| Q4 25 | 7.8% | 14.7% | ||
| Q3 25 | 20.7% | 15.3% | ||
| Q2 25 | -7.3% | 11.3% | ||
| Q1 25 | 10.0% | 12.2% | ||
| Q4 24 | 23.9% | 11.6% | ||
| Q3 24 | -11.2% | 14.5% | ||
| Q2 24 | -0.5% | 10.4% | ||
| Q1 24 | -0.5% | 10.3% |
| Q4 25 | $2.34 | — | ||
| Q3 25 | $7.76 | — | ||
| Q2 25 | $-2.95 | — | ||
| Q1 25 | $3.33 | — | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $176.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $941.0M |
| Total Assets | $918.5M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $176.6M | ||
| Q3 25 | $166.0M | $119.8M | ||
| Q2 25 | $96.7M | $170.5M | ||
| Q1 25 | $84.7M | $176.6M | ||
| Q4 24 | $40.6M | $194.6M | ||
| Q3 24 | $46.9M | $163.2M | ||
| Q2 24 | $40.8M | $131.2M | ||
| Q1 24 | $30.0M | $159.4M |
| Q4 25 | $329.4M | $941.0M | ||
| Q3 25 | $317.2M | $918.9M | ||
| Q2 25 | $235.3M | $893.1M | ||
| Q1 25 | $176.9M | $879.4M | ||
| Q4 24 | $132.4M | $870.7M | ||
| Q3 24 | $60.4M | $870.2M | ||
| Q2 24 | $62.7M | $841.4M | ||
| Q1 24 | $63.0M | $834.4M |
| Q4 25 | $918.5M | $1.3B | ||
| Q3 25 | $964.5M | $1.2B | ||
| Q2 25 | $841.0M | $1.2B | ||
| Q1 25 | $761.9M | $1.1B | ||
| Q4 24 | $655.3M | $1.1B | ||
| Q3 24 | $438.5M | $1.1B | ||
| Q2 24 | $422.4M | $1.1B | ||
| Q1 24 | $404.3M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $73.3M |
| Free Cash FlowOCF − Capex | $69.0M | $61.0M |
| FCF MarginFCF / Revenue | 45.5% | 31.1% |
| Capex IntensityCapex / Revenue | 0.9% | 6.3% |
| Cash ConversionOCF / Net Profit | 5.95× | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $96.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $73.3M | ||
| Q3 25 | $99.5M | $62.2M | ||
| Q2 25 | $27.3M | $-8.5M | ||
| Q1 25 | $51.0M | $3.6M | ||
| Q4 24 | $54.0K | $68.8M | ||
| Q3 24 | $6.8M | $61.3M | ||
| Q2 24 | $13.3M | $-12.6M | ||
| Q1 24 | $3.1M | $21.4M |
| Q4 25 | $69.0M | $61.0M | ||
| Q3 25 | $99.2M | $50.7M | ||
| Q2 25 | $26.5M | $-16.0M | ||
| Q1 25 | $50.9M | $750.0K | ||
| Q4 24 | $-341.0K | $64.7M | ||
| Q3 24 | $6.2M | $55.8M | ||
| Q2 24 | $12.7M | $-16.6M | ||
| Q1 24 | $2.3M | $16.9M |
| Q4 25 | 45.5% | 31.1% | ||
| Q3 25 | 37.0% | 21.8% | ||
| Q2 25 | 10.9% | -10.3% | ||
| Q1 25 | 24.0% | 0.5% | ||
| Q4 24 | -0.1% | 33.5% | ||
| Q3 24 | 7.8% | 24.7% | ||
| Q2 24 | 16.7% | -11.0% | ||
| Q1 24 | 3.4% | 11.0% |
| Q4 25 | 0.9% | 6.3% | ||
| Q3 25 | 0.1% | 5.0% | ||
| Q2 25 | 0.3% | 4.8% | ||
| Q1 25 | 0.0% | 1.9% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | 0.8% | 2.4% | ||
| Q2 24 | 0.7% | 2.6% | ||
| Q1 24 | 1.1% | 2.9% |
| Q4 25 | 5.95× | 2.55× | ||
| Q3 25 | 1.80× | 1.74× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | 2.40× | 0.20× | ||
| Q4 24 | 0.00× | 3.06× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | -0.81× | ||
| Q1 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
TR
| Products | $194.3M | 99% |
| Rental And Royalty | $1.9M | 1% |
